Compound Monograph — PX-GHK
GHK-Cu
Copper tripeptide — glycyl-L-histidyl-L-lysine Cu(II) complex
For laboratory research use only. Not for human or veterinary use.
Compound data
- Compound class
- Copper-binding tripeptide complex
- Structure
- Glycyl-L-histidyl-L-lysine complexed with Cu(II)
- Molecular formula
- C14H24CuN6O4
- Molar mass
- ≈ 403.9 g/mol (complex)
- CAS number
- 49557-75-7
- Natural occurrence
- Endogenous in human plasma, saliva, and urine; declines with age in published data
- Presentation
- Lyophilized powder — 50mg and 100mg vials
- Purity specification
- ≥ 99% by HPLC, identity confirmed by LC-MS
Overview
GHK-Cu is a naturally occurring copper complex of the tripeptide glycyl-L-histidyl-L-lysine, first isolated from human plasma in 1973 by Loren Pickart. The tripeptide has a high affinity for copper(II) ions, and the resulting complex is the biologically studied form.
Published research places GHK-Cu among the most studied cosmetic and dermatological-model peptides, with a literature spanning skin-model endpoints, wound-context models, and gene-expression studies. A frequently cited data point in the literature is the age-related decline of endogenous GHK-Cu plasma levels.
Mechanism in the research literature
Copper delivery and enzyme cofactor context
GHK functions as a copper(II) carrier in published models. Copper is an essential cofactor for enzymes including lysyl oxidase and superoxide dismutase, both of which appear in the connective-tissue and antioxidant research contexts associated with GHK-Cu.
Gene-expression findings
Published gene-expression profiling work has reported that GHK modulates the expression of a substantial number of human genes in cell-culture models, with enrichment in matrix-remodeling and repair-associated pathways — the basis of much of its research interest.
Matrix metalloproteinase context
Published studies have examined GHK-Cu's interaction with metalloproteinase and antiproteinase expression in skin-model systems, framing its role in extracellular-matrix research.
Published research summary
- Isolated from human plasma in 1973; the founding publications describe its growth-modulating activity in hepatocyte culture models.
- Published gene-array studies report broad expression modulation in cultured human cells, concentrated in repair and matrix pathways.
- An extensive cosmetic-formulation literature examines GHK-Cu in topical skin-model endpoints.
- Every PX-GHK batch is released against ≥ 99% HPLC purity with LC-MS identity confirmation and a lot-specific Certificate of Analysis.
Handling, reconstitution & storage
- Storage (lyophilized)
- -20 °C long term; 2–8 °C short term; protect from light
- Reconstitution
- Bacteriostatic water down the vial wall; the solution will present a characteristic blue tint from the Cu(II) complex
- Example ratio
- 50mg vial + 2.0 mL diluent = 25 mg/mL
- Stability (reconstituted)
- Reference ≈ 28–30 days refrigerated at 2–8 °C with bacteriostatic water
- Light sensitivity
- Protect both lyophilized and reconstituted material from light
Frequently asked questions
Research use only. GHK-Cu (PX-GHK) is supplied exclusively as a laboratory research compound. It is not a drug, food, or cosmetic, and it is not intended for human or veterinary administration, diagnostic use, or household use. Statements on this page summarize published scientific literature for reference purposes and do not constitute medical advice or health claims. All PX1 Research batches ship with lot-specific Certificates of Analysis confirming ≥ 99% purity by HPLC and identity by LC-MS.